DMK Pharmaceuticals Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$16.29 | Buy/Sell | $11.59 | 4.36% | 9 | $18.45B |
| HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.78 | Buy/Sell | £28.11 | 47.67% | 9 | £4.42B |
| AMPH | Amphastar Pharmaceuticals | Outperform |
14
|
$43.48 | Buy/Sell | $69.00 | 42.59% | 0 | $2.09B |
| SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$29.10 | Buy/Sell | $41.00 | 40.89% | 0 | $1.72B |
| ANIP | ANI Pharmaceuticals | Buy |
13
|
$61.43 | Buy/Sell | $69.75 | 30.23% | 1 | $1.38B |
| IRWD | Ironwood Pharmaceuticals | Buy |
14
|
$6.48 | Buy/Sell | $17.83 | 139.20% | 2 | $1.29B |
| COLL | Collegium Pharmaceutical | Outperform |
11
|
$32.47 | Buy/Sell | $37.75 | 23.19% | 1 | $1.24B |
| PCRX | Pacira BioSciences | Outperform |
16
|
$30.82 | Buy/Sell | $47.90 | 42.76% | 6 | $1.23B |
| BDSI | BioDelivery Sciences Internati... | - |
11
|
$5.59 | Buy/Sell | $10.00 | 16.46% | 0 | $577.05M |
| AQST | Aquestive Therapeutics | Buy |
0
|
$3.11 | Buy/Sell | $6.33 | 189.39% | 0 | $307.71M |
| EBS | Emergent BioSolutions | Outperform |
16
|
$5.55 | Buy/Sell | $5.00 | -9.91% | 0 | $229.00M |
| ZVRA | Zevra Therapeutics | Buy |
10
|
$4.73 | Buy/Sell | $19.50 | 291.12% | 1 | $204.66M |
| DCTH | Delcath Systems | Buy |
0
|
$7.57 | Buy/Sell | $19.25 | 190.62% | 1 | $196.44M |
| ASRT | Assertio Holdings | Buy |
8
|
$1.07 | Buy/Sell | $3.50 | 180.37% | 2 | $100.36M |
| DRRX | DURECT | Outperform |
9
|
$0.93 | Buy/Sell | $6.75 | 813.98% | 2 | $33.21M |
| CPIX | Cumberland Pharmaceuticals | - |
0
|
$2.03 | Buy/Sell | $8.50 | -100.00% | 0 | $24.38M |
| ACRX | AcelRx Pharmaceuticals | Outperform |
6
|
$1.08 | Buy/Sell | $4.63 | 293.52% | 0 | $17.33M |
| ACOR | Acorda Therapeutics | - |
5
|
$0.43 | Buy/Sell | $200.00 | -100.00% | 1 | $0.53M |